Champions Oncology Stock (NASDAQ: CSBR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 4.144K |
Day Range | - - - |
52 Wk Range | 4.170 - 7.320 |
Market Cap | $76.805M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 0.84% |
Days to Cover | 14.85 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Champions Oncology (NASDAQ: CSBR) through any online brokerage.
Other companies in Champions Oncology’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), Personalis (NASDAQ:PSNL), Quantum-Si (NASDAQ:QSI) and Applied DNA Sciences (NASDAQ:APDN).
The latest price target for Champions Oncology (NASDAQ: CSBR) was reported by Craig-Hallum on Wednesday, March 13, 2024. The analyst firm set a price target for 0.00 expecting CSBR to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for Champions Oncology (NASDAQ: CSBR) is $5.65 last updated March 12, 2024 at 7:15 PM EDT.
There are no upcoming dividends for Champions Oncology.
Champions Oncology’s Q4 earnings are confirmed for Monday, July 22, 2024.
There is no upcoming split for Champions Oncology.
Champions Oncology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.